Increased plasma levels of glucagon (hyperglucagonaemia) are associated with fasting hyperglycaemia in people with type 2 diabetes but are also observed in individuals with obesity and/or MASLD [6–8]. This evidence concerns the gene GCG and type 2 diabetes mellitus.